Can high molecular weight cytokeratin, CK-903, differentiate benign proliferative breast lesions from atypical ductal hyperplasia and ductal carcinoma in situ?

被引：0
|
作者：
Aziz, M. [1 ]
Troob, S. [1 ]
Simpson, S. [1 ]
Mills, C. [1 ]
Bernik, S. [1 ]
机构：
[1] St Vincents Comprehens Canc Ctr, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
86
引用
收藏
页码：23A / 23A
页数：1
相关论文
共 24 条
  • [21] Stereotactic, 11-gauge, vacuum-assisted breast biopsy: Can a subset of atypical ductal hyperplasia lesions be defined post-biopsy as being probably benign?
    Jackman, RJ
    Birdwell, RL
    Ikeda, DM
    RADIOLOGY, 2001, 221 : 378 - 379
  • [22] The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (OCIS) in patients (pts) treated with breast conserving therapy (BCT).
    Adepoju, LJ
    Symmans, WF
    Babiera, GV
    Singletary, SE
    Sneige, N
    Buchholz, TA
    Hunt, KK
    Meric-Bernstam, F
    Arun, B
    Kuerer, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 36S - 36S
  • [23] Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast
    Maeda, Ichiro
    Tajima, Shinya
    Kanemaki, Yoshihide
    Tsugawa, Koichiro
    Takagi, Masayuki
    SAGE OPEN MEDICINE, 2018, 6
  • [24] Atypical ductal hyperplasia: Histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy
    Brem, RF
    Behrndt, VS
    Sanow, L
    Gatewood, OMB
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (05) : 1405 - 1407
123